On Chen, MD, and Tahmid Rahman, MD discuss how plozasiran—an RNA-based APOC3-targeting therapy for patients with familial chylomicronemia syndrome with infrequent injections and a favorable safety profile—can transform care when integrated through coordinated multidisciplinary workflows with pharmacists leading patient identification, access, and monitoring.

You can find Dr. Joshi on LinkedIn here.

Read more essential insights on PharmacyTimes.com.

William Van Decker, MD, discusses the key priorities of the upcoming ACC Legislative Conference, including telehealth, cardiovascular rehab, prior authorization reform, and the role of pharmacists in shaping patient-centered cardiovascular policy.

Lung cancer remains one of the leading causes of cancer-related death, yet many cases occur in people who have never smoked. One often-overlooked culprit is radon, a naturally occurring radioactive gas and the second leading cause of lung cancer.

How a new house bill could protect patient access after the IRA.

0:48: Intro

1:35: Common mistakes with inhalers

5:25: Tailoring inhaler education

9:10: Selecting the right inhaler for a patient

12:05: What an inhaler counseling session looks like

15:45: Tracking inhaler technique

18:06: Inhaler counseling in community pharmacies

21:24: Conclusion

Jennifer Griffin, PharmD, MS, serves as a clinical pharmacist for Harps Food Stores, Inc., where she specializes in medical billing, point-of-care testing and treatment workflow, and marketing clinical services. She earned her Doctor of Pharmacy degree from Harding University College of Pharmacy in Searcy, Arkansas, and holds a Bachelor of Science in Healthcare Administration and a Master of Science in Health Promotion from the University of Central Arkansas.